Radoff Bradley Louis's Form 4 filing
Enzo Biochem Inc (ENZB) · filed Jul 6, 2022
- Accession no.
- 0001213900-22-037633
- Filed
- Jul 6, 2022
- Trade date
- Jul 5, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $264.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Radoff Bradley LouisCIK 0001380585 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 5, 2022 | Common Stock, $0.01 Par Value | PPurchaseAcquired | +120,000 | $2.20 | +$264,000 | 4,182,163 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.